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ABSTRACT 
Whole blood serum is widely recognized as essential for the growth of diploid cells 
in culture. Dermal fibroblasts and arterial smooth muscle cells fail to proliferate in 
culture in the presence of serum derived from platelet-poor plasma. Platelet-poor 
plasma  serum  is  capable  of  maintaining  monkey  arterial  smooth  muscle  cells 
quiescent  in  culture  at  either  low  (1.5  x  l0  s)  or  high  (2.0  x  10 ~)  population 
densities.  The proportion  of cells traversing the cell cycle under these conditions 
was approximately 3%.  Equal numbers of quiescent smooth muscle cells initiated 
DNA synthesis and cell division when treated with whole blood serum or with an 
equivalent  quantity  of platelet-poor plasma serum  supplemented with  a  factor(s) 
derived  from a  supernate  obtained  after exposure of human  platelets to purified 
thrombin in vitro. 
Exposure  of  quiescent  cells  to  5%  whole  blood  serum  or  5%  platelet-poor 
plasma  serum  plus  5  tzg/ml  of  crude  platelet  factor(s)  preparations  for  1  h 
stimulated as many cells to initiate DNA synthesis as did exposure for 24 hr, and 
was independent  of the cell densities  used  in these experiments.  Thus, one of the 
principal mitogens for fibroblasts and  for arterial  smooth muscle cells in culture 
present in  all blood sera thus  far examined appears to be derived from platelets. 
The system of diploid  fibroblasts or smooth muscle cells grown in serum lacking 
platelet factor(s) permits one to use cells quiescent in the presence of optimal levels 
of serum and of the low molecular weight components of the defined medium for 
the study of growth control in culture. This system also permits the study of smooth 
muscle  proliferation  as  it  may  relate  to  the  proliferative  response  observed  in 
atherogenesis in vivo. 
Recently, attention has been focused on the role of 
arterial smooth muscle cells in the pathogenesis of 
arteriosclerosis  (11,  14). Focal  proliferation  of 
smooth muscle  cells in the intima of the affected 
arteries is the principal early feature of the devel- 
opment of the lesions  of atherosclerosis, however, 
the  events  preceding  this  proliferation  and  the 
factors that are important in the initiation  of this 
cellular  accumulation  are  not  well  understood. 
Ross and Glomset (14) have suggested  that endo- 
thelial  "injury" leads to exposure of subendothelial 
connective tissue  with  resultant  platelet  aggrega- 
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lets;  subsequently,  smooth  muscle  cells  migrate 
into and proliferate within the intima at the site of 
injury (14,  16).  In addition,  the release of platelet 
material  as  a  result  of  bloodclotting  in  a  skin 
wound  could  play  a  role  in  the  migration  and 
proliferation  of dermal  fibroblasts  that  occur  in 
healing. We are presently examining these hypoth- 
eses with the use of an  in vitro model. 
In  vitro  primate  (Macaca  nemestrina)  arterial 
smooth  muscle  cells  (SMC)  reach  significantly 
greater cell population densities when treated with 
medium  supplemented  with  serum  derived  from 
homologous  whole  blood  (WBS)  than  when 
treated  with  serum  derived  from  homologous 
platelet-poor plasma  (PPPS).  Smooth  muscle cell 
cultures  treated  with  medium  supplemented  with 
platelet-poor plasma  serum (PPPS) to which puri- 
fied  platelets  were  added  before  clotting,  or  with 
PPPS  enriched  with  the supernate  from  a  throm- 
bin-induced in vitro platelet release reaction, reach 
densities  equal  to  those  obtained  in  whole  blood 
serum (WBS)-treated cultures (16). These observa- 
tions suggested that platelets release material that 
enhances  the  proliferation  of  SMC  in  culture. 
Other investigators have published data describing 
the  diminished  capacity  of plasma  to support  the 
growth of chicken fibroblasts (1) and the presence 
in  platelets  of  "growth-promoting  activity"  for 
3T3 cells (9). 
Here  we  report  the  responses  of dermal  fibro- 
blasts  and  arterial  smooth  muscle  cells from  the 
same  animal  (M. nemestrina) to  the growth-pro- 
moting  substances  present  in  different  prepara- 
tions of homologous sera. The principal interest in 
our  laboratory  is  directed  toward  understanding 
the biology of the smooth muscle cell, the nature of 
the  response  of  these  cells  to  material  released 
from platelets, and the factors important in induc- 
ing smooth  muscle proliferation  in atherogenesis. 
Therefore, the majority of the experiments in this 
report  were designed  to answer  specific questions 
concerning the nature  of the response of quiescent 
cultured smooth muscle cells to treatment with the 
supernate from an in vitro platelet release reaction 
(16),  or fractions of this material  which have been 
shown  to  stimulate  proliferation  of SMC  in  cul- 
tures  (unpublished  observations).  These  experi- 
ments  were  carried  out  to  determine:  (a)  the 
growth  fraction  (fraction  of total  cell population 
traversing  the  cell  cycle)  of cells  previously  ren- 
dered  quiescent  in  culture  in  medium  containing 
platelet-poor  plasma  serum  (PPPS);  (b)  the  ki- 
netics  of  the  onset  of  DNA  synthesis  and  cell 
division  in  quiescent  cultures  of varying densities 
treated  with  PPPS  supplemented  with  platelet 
release  material  (platelet  factors,  PF)  or  whole 
blood serum (WBS); and (c) the minimum time of 
exposure of cells to W BS or PPPS + PF-containing 
medium  that  will result  in  a  maximal increase  in 
the number of cells engaged in DNA synthesis. 
MATERIALS  AND  METHODS 
Cell Cultures 
SMC  were  subcultured  from  explants  of  M. 
nemestrina thoracic aortas according to previously pub- 
lished methods (12). The dermal fibroblasts were subcul- 
tured from skin  biopsies  of the same animals (13). The 
cells  were  grown  in  Dulbecco-Vogt's  modification  of 
Eagle's basal medium (M DV) supplemented with varying 
concentrations of homologous whole blood serum (WBS) 
or with equivalent (on a protein basis) concentrations of 
platelet-poor  plasma  serum  (PPPS)  derived  from  the 
same donor pool of blood. Equivalence calculations were 
based  upon  the  protein  concentrations  of  PPPS  after 
dialysis.  These values ranged from 58 to 65 mg/ml (see 
next section).  The cells were kept at 37~  in a moist 5% 
CO2  95%  air atmosphere.  Assays  of cell accumulation 
were performed as described 05,  16). 
Preparation  of Sera from  Whole Blood and 
Platelet-Poor Plasma 
Blood was periodically drawn into 3.5% sodium citrate 
(0.35% or 13 jzmol/ml final concentration) from each of 
four adult male M. nemestrina, pooled, and divided into 
two fractions for preparation of WBS and PPPS. Blood 
specimens from  four donors  were  pooled to avoid the 
commonly observed  but poorly understood toxicity often 
seen  in  serum  from single  donors. The fraction for the 
preparation of WBS was kept at room temperature until 
small  aliquots  were  removed  for  platelet  counts  and 
hematocrits. Calcium was then added  to the remaining 
blood to 14 amol/ml Ca ++ and the blood was incubated 
at 37~  for 2 h.  Higher calcium levels had no effect on 
the growth of the cells in culture. After clot formation the 
blood  was  centrifuged  in  an  SS  34  rotor  (Dupont 
Instruments,  Sorvall Operations,  Newtown,  Conn.)  at 
3,000  rpm  for  15  min at 4~  The supernate was  then 
centrifuged at 13,500 rpm for 30 min at 4~  pooled, and 
dialyzed against Ringer's solution  at 4~  for 24 h (three 
changes).  The serum was incubated at 56~  for 30 min, 
filtered,  and  frozen  at  -70~  Aliquots  were  taken 
before  and  after  dialysis  for  determination  of protein 
concentration (10). The fraction to be prepared as PPPS 
was  placed  at 4~  immediately after drawing and  the 
formed elements were  sedimented at 4~  at 3,000  rpm 
for 30 rain.  The supernates  were decanted  and  pooled. 
The plasma was  incubated at 4~  for 3 h, calcium was 
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at 37~  for 2 h. The clot was sedimented at  13,500  rpm 
for 30  min  at  4~  The  serum  was decanted and  then 
handled  exactly  as  that  prepared  from  whole  blood. 
Before clotting, the blood was handled in siliconized glass 
or plastic vessels. The dialysis tubing (Dialya-Por, Na- 
tional Scientific, Cleveland, Ohio) had an exclusion limit 
of 6,000  8,000 mol wt. 
Preparation of Platelet Release Material 
Human  blood-bank  platelets  were  purified  (18)  and 
released in  vitro  by treatment  with  thrombin as previ- 
ously  reported  (16).  This  material,  termed  the  whole 
release fraction, was utilized in  some experiments on a 
platelet per  milliliter concentration equal to twice that 
found in the blood from which the PPPS was prepared 
(16).  The whole release fraction was further purified by 
chromatography  on  carboxymethyl-Sephadex  (G-50- 
Pharmacia).  The column  was developed by a  step-wise 
addition of 0.1  M  Tris (pH  7.4), 0.1  m  NaCI  +  0.1  M 
Tris, and 1.0 M NaCI +  0.1 M Tris. The material eluting 
at  1.0 M NaC1 still contained several proteins as seen on 
acrylamide and SDS gels and brought about an increase 
in  the  number  of SMC  in  vitro  (Glomset  and  Ross, 
unpublished observations). It was utilized at a concentra- 
tion  of  5  ,g  protein  per  milliliter  of medium  and  is 
referred to in the text as platelet factor(s) (PF). 
Steady-State  Cultures at Different Densities 
SMC were plated on round, 25-mm diam plastic cover 
slips (Lux Scientific) and the cover slips were placed in 
35-mm  plastic culture dishes (Falcon  Plastics, Oxnard, 
Calif., or Corning Glass Works, Science Products Div., 
Corning,  N.Y.)  at  densities which varied initially by a 
factor  of five.  Actual  cell densities varied between ex- 
periments and  are  presented in  the  appropriate  figure 
legends. 16-18 h after plating, an equal number of cover 
slips  with  cells  from  each  density  group  were  placed 
into  100-mm  plastic dishes containing  10  ml  of MDV 
containing  5%  PPPS.  These  cultures  were  then  refed 
every  48  h  and  cell  accumulation  was  monitored  by 
daily counts of the cells in one 100-mm dish (two or three 
cover slips per density group).  For counting, the cover 
slips with cells were washed in isotonic Tris-Versene and 
then  placed  singly in  35-mm dishes containing  1 ml of 
0.05%  trypsin  (Difco  Laboratories,  Detroit,  Mich.)  in 
Tris-Versene  and  incubated  for  10  min  at  37~  The 
cover slips were then rinsed five times with the  1 ml of 
trypsin cell suspension which was pipetted into an equal 
volume of 20% Formalin in a 50-50 mixture of PBS and 
methanol.  The cells were counted  in  a  Cytograf (Bio/ 
Physics Systems, Inc.,  Mahopac, N.Y.).  Cultures  were 
considered  to  be  in  a  steady  state  as  regards  cell 
accumulation  when  there  was  no  net  change  in  cell 
density over a 48-h period. Cultures typically reached this 
state 4  7 days after transfer to PPPS medium. 
The effect of WBS and platelet factors was tested on 
steady-state SMC on cover slips. These cover slips were 
removed  from  the  PPPS  medium,  washed  twice  in 
Tris-Versene, and equal numbers of cover slips from each 
density group were placed in the appropriate test medium 
in new 100-mm plastic dishes. 
Labeling with [SH]Tdr and [SH] Tdr 
A utoradiography 
Two  different  labeling  protocols  were  utilized.  In 
experiments designed to determine the growth  fraction 
(fraction of total cell population traversing the cell cycle), 
steady-state cells were exposed to 0.1  /~Ci/ml [+H]Tdr 
(sp act 6.7 Ci/mmol) for varying time-periods up to 48 h. 
For other experiments, 0.2/~Ci/ml  [+H]Tdr was added 
for  1  h  at  different  times  between  the  treatment  of 
steady-state cells with WBS, PPPS+PF, or PPPS, and 
the onset of a measurable increase in cell number. At the 
end of the labeling period, the cover slips were removed, 
washed  by  sequential  immersions  in  PBS,  fixed  with 
Formalin  (7),  air  dried,  and  mounted  on  microscope 
slides with Permount. The slides were dipped into Kodak 
NTB-2  emulsion  (40~  air  dried  for  1  h,  and  then 
stored at 4~  for 10-14 days. The autoradiographs were 
developed  in  Dektol,  rinsed  in  running  water,  stained 
with hematoxylin and eosin, and dehydrated in successive 
ethanol  baths.  The  fraction  of labeled  nuclei  (labeling 
index, [4]) was determined at a magnification of 250 in a 
Zeiss photoscope. The total number of nuclei counted for 
each determination is presented in the respective figure 
legends. 
The limited number of cells obtained from each group 
of explants prevented the use of more than three cover 
slips per density group at each time-point in any of these 
experiments. This  restriction was particularly  stringent 
when  cells  subcultured  from  the  explants  of a  single 
donor were utilized for different experiments. Therefore, 
each experiment was repeated on cells from three or four 
different  donors,  and  large  numbers  of  nuclei  were 
counted  for  each  determination,  One  representative 
experiment of each type is included in this report.  The 
growth fraction of quiescent smooth muscle cells varied 
from 3% to 5% among different donor animals (Fig. 2). 
The  maximum  labeling  index  after  a  l-h  pulse  with 
[SH]thymidine 24 h  after introduction of the test agent 
varied from 10% to 20% among different donor animals. 
However, the kinetics of initiation of DNA synthesis and 
cell division and  the duration  of treatment  required  to 
initiate these responses were highly reproducible among 
several experiments in which cells from different donors 
were utilized (Figs. 3 and 4). 
RESULTS 
Proliferative Response of Fibroblasts and 
Smooth Muscle Cells to Platelet-Poor 
Plasma Serum 
The  growth  curves  in  Fig.  1  compare  the  re- 
sponses  of  skin  fibroblasts  and  arterial  smooth 
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FIGURE I  The accumulation of dermal fibroblasts (b) and arterial smooth muscle ceils (a) in the presence 
of whole blood serum, platelet-poor plasma serum, or platelet-poor plasma serum plus platelet factor is 
plotted as a function of time. Initially, 3 ￿  10 ~ cells were plated in 35-mm dishes in 1% whole blood serum 
medium and refed every 48 h. At day 7, the appropriate test media were added and daily counts were made 
from triplicate dishes. Variation among dishes averaged less than  10%. 
muscle cells from the same animal to whole blood 
serum  and  platelet-poor  plasma  serum  (PPPS) 
prepared from the same blood pool. Fibroblasts as 
well  as  smooth  muscle  cells  cultured  in  PPPS 
medium  fail to  accumulate  to  the  same  levels as 
cells  cultured  in  whole  blood  serum  (WBS)-con- 
taining  medium.  While  there  were  variations 
among final population densities achieved and the 
slopes of the curves, the data clearly demonstrate 
that  the  material  released  from  platelets  re- 
stores the mitogenic capacity present in WBS and 
lacking in  PPPS  for  both homologous fibroblasts 
and arterial smooth muscle cells. 
Definition of Quiescent Cells 
Smooth muscle cells cultured for 4-7 days in 5% 
PPPS  medium  that  was  replaced  every  48  h 
showed no net change in cell number (steady state). 
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ing  the  cell  cycle  under  these  conditions  was 
approximately  3% in the experiment depicted here 
and  was  not  significantly  different  for  cells  cul- 
tured at the two different population densities (Fig. 
2).  We defined steady-state cells as quiescent when 
the  growth  fraction  as  determined  by continuous 
labeling  with  [3H]Tdr  (2)  was  5%  or  less.  The 
sharp increase in the labeling index between 15 and 
20 h observed in Fig. 2 probably represents partial 
synchrony  of the  cell  population.  The  reason  for 
this is unknown. 
Kinetics of Onset of DNA Synthesis and Cell 
Division in Quiescent Cells 
Quiescent  smooth  muscle  cells  maintained  in 
replenished  5%  platelet-poor  plasma  serum 
(PPPS) at different culture densities had a labeling 
index  (2)  of less  than  I%  (Fig.  3).  Treatment  of 
these  cells  with  whole  blood  serum  (WBS)  or 
PPPS  plus  platelet  factor  (PF)  resulted  in  an 
increase  in  the  fraction  of S-phase  cells (labeling 
index) followed by a  net increase in the number of 
cells. In no experiments did the peak labeling index 
exceed  20%,  and  it  usually  ranged  between  10% 
and  15%  at 24 h after treatment.  The cell popula- 
tion densities doubled within 48  60 h after a single 
treatment with either WBS or PPPS+PF.  Control 
cultures  fed  with  medium  containing  only  PPPS 
demonstrated  minimal change in the labeling index 
or culture density. 
Quiescent  smooth  muscle  cells  maintained  at 
several different initial culture densities varying by 
three-  to  five-fold demonstrated  no differences in 
their  response  to  WBS  or  PPPS+PF.  In  these 
experiments, direct comparison of the response of 
cells  at  different  population  densities  could  be 
made  since  an  equal  number  of cover slips  from 
each density group was placed in the test medium. 
The variation in cell number among cover slips was 
5%  for  the  high  density  and  10%  for  the  low 
density groups. 
Effect of Varying Exposure  Times of 
Quiescent Cells to Platelet Factors 
The cultures utilized to study the kinetics of the 
initiation of DNA synthesis and cell division were 
maintained  in the appropriate test medium for the 
duration  of the experiment.  To estimate the mini- 
mum time of exposure to the test  agents that  was 
required  to  initiate  cell  cycle  traverse,  quiescent 
cells  were  treated  with  WBS  or  PPPS+PF  for 
varying  periods  of  time.  Cells  treated  for  1  h 
manifested  the  same  labeling  index  24  h  after 
treatment as did cells treated for 24 h (Fig. 4). This 
result  was  also  obtained  in  experiments  in  which 
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FIGURE 2  This experiment demonstrates the accumulation of labeled nuclei in continuously labeled cul- 
tures of steady-state SMC ceils treated with 0.1 #Ci/ml [SH]Tdr (sp act 6.7 Ci/mmol) in medium supple- 
mented with homologous plasma-derived serum lacking platelet factor(s) (PPPS) to a final concentration 
of 5%. ['H]Tdr was added  24 h after a medium change in cultures which were at a steady state for 4 days 
before the start  of the experiment. At each specified  interval, three cover slips from each density group 
were removed and processed  for autoradiography.  1,000-1,200  nuclei were counted per cover slip and the 
average labeling  index (percent labeled  cells) was calculated for the high and low density cover slips. The 
variation among cover slips for each time-period was less than  10%. At time zero, cell population densities 
for this experiment were 3.3  x  l0 s cells/cm  2 and  1.2 x  10 ~ cells/cm  2. Low density cultures, r-l; high den- 
sity cultures,  I. 
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FIGURE 3  The kinetics of onset of DNA synthesis (a) 
and cell division (b) in SMC maintained in 5% plasma- 
derived serum lacking platelet factor(s) (PPPS) medium 
and treated  at  time zero with 5%  whole blood serum 
(WBS), 5% PPPS +  5 ~tg/ml platelet factor(s) (PF), or 
5% PPPS alone. At intervals after treatment, cells from 
each treatment group were labeled with 0.2 ~.Ci/ml (fi- 
nal concentration diluted in the particular test medium) 
[SH]Tdr (sp act 6.7 Ci/mmol) for I h and then processed 
for autoradiography. The initial cell densities were 6 ￿ 
l0  s cells/cm 2 and 1.8 ￿  104 cells/cm 2. Each point in Fig. 
a  represents the  average labeling index of three cover 
slips per density group, with 800-1,000 nuclei counted 
o  per cover slip. WBS,  ; PPPS,  ; PPPS,  +  PF ￿9  ; 
high density, solid; low density, open. 
the  whole  release  material  was  utilized.  Again, 
there  were  no  apparent  differences  in  response 
among  cultures  of  different  densities.  The  cell 
number for each group, except those treated with 
PPPS, doubled by 60 h after treatment (data not 
shown). 
DISCUSSION 
These  experiments  were  designed  to  provide  a 
system for studying the events that are important 
in the initiation of in vitro proliferation of smooth 
muscle cells and fibroblasts. Our approach was (a) 
to optimize conditions necessary to maintain cells 
quiescent in vitro; (b) to stimulate quiescent cells 
to initiate DNA synthesis and cell division; and (c) 
to study the effects of cell population density and 
duration of stimulatory treatment on the transition 
from quiescence to growth. 
Quiescent Smooth  Muscle  Cells 
Cells  in  culture  have  usually  been  rendered 
quiescent by relative nutrient or serum starvation 
at very low (1% or less)  serum concentrations (5 
8),  or by being grown to a  stationary phase at a 
particular  serum  concentration (22),  which  may 
represent another form of serum deprivation. The 
fact that  smooth muscle cells in culture failed to 
proliferate in 5%  PPPS (16)  suggested that these 
cells could be rendered quiescent in this medium. 
Our results clearly confirm this idea (Figs.  1-3). 
Cells cultured in defined medium or in very low 
concentrations of serum  tend, with time,  to  lose 
their capacity to respond to mitogenic stimuli (3). 
The present studies demonstrate that after 7 days 
in  platelet-poor  plasma  serum  (PPPS)  medium, 
quiescent cells responded in a quantitatively  equiv- 
alent  manner to  the  mitogenic effects  of either 
WBS  or  platelet  factor(s),  and  that,  within the 
limits  of  population  sizes  and  the  serum  and 
platelet factor concentrations used in these studies, 
this  response  was  independent of cell population 
density (Figs. 3 and 4). These data and those from 
Fig.  1  suggest  that  platelet-poor  plasma  serum 
provides the necessary factors for the maintenance 
of cells in culture and that the principal mitogen in 
whole  blood  serum  for  both  cultured  arterial 
smooth  muscle  cells  and  dermal  fibroblasts  is 
derived from platelets. 
Factors  derived  from  platelets  may  also  be 
important  in  response  to  injury.  Dermal  fibro- 
blasts would only be in contact with serum, or with 
material released  from  thrombocytes by clotting 
during injury such as in wound repair. Similarly, in 
vivo  smooth  muscle  cells  would  not  come  into 
contact  with  these  agents except  during platelet 
aggregation and release. This could occur at foci of 
endothelial cell damage where  platelets could be 
exposed  to  collagen  or  other  constituents  that 
would stimulate the release reaction. 
Thomas (21) has obtained data from swine that 
suggest that in vivo the growth fraction of arterial 
medial smooth muscle is small. Therefore, smooth 
muscle  cells  quiescent  in  platelet-poor  plasma 
serum  may  be  more  analogous  to  intact  tissue 
when  cells  would  normally contact plasma  or  a 
filtrate of plasma but  not  serum; therefore,  this 
may represent a more physiological model for the 
study of the effects of platelet factor(s) and other 
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FIGURE 4  The fraction of SMC in S after treatment of quiescent cells for varying periods of time with 5% 
homologous whole blood serum (WBS) or 5% plasma-derived  serum lacking platelet factor(s)  (PPPS) + 
5 jag/ml platelet factor (PF). At 24 h after replenishing the PPPS medium, equal numbers of cover slips 
from each density group were placed into the different test media and, after the indicated periods of time, 
the cover slips were washed three times with Tris-Versene  and then replaced into the same PPPS medium 
from which they were removed.  Incubation was continued so that each group was incubated for 24 h after 
initiation of treatment. All ceils were then labeled with 0.2 #Ci/ml [aH]Tdr (sp act 6.7 Ci/mmol) for  1 h 
(at 24-25 h after start of treatment) and processed  for  autoradiography. The labeling index represents 
the percentage  of cells in S between 24 and 25 h after initiation of treatment. 800-1,000 nuclei per cover 
slip  were counted, and the average  labeling index  was calculated from three cover  slips per treatment 
point, WBS, ~; PPPS +  PF, w  O; PPPS, aa  toO; high density, solid; low density, open.  group per 
"growth-promoting"  agents  on  the  initiation  of 
proliferation of these cells. 
Initiation of DNA Synthesis and Cell 
Division in  Quiescent Smooth Muscle Cells 
Quiescent  SMC  respond  to  treatment  with 
whole blood serum (WBS) or platelet-poor plasma 
serum  and  platelet  factor(s)  (PPPS+PF)  by  an 
increase in the proportion of cells that  synthesize 
DNA  and  subsequently  by  a  doubling  of  the 
culture  density  (Fig.  3).  The  sequence  of events 
after  stimulation suggests  that  the  population of 
SMC, quiescent in PPPS and responsive to treat- 
ment  with  WBS  or  PPPS+PF,  resides  in  the 
Ga(G,) stage of the cell cycle. Other cells in culture 
rendered  quiescent  by  nutrient limitation, serum 
starvation, or growth to high culture densities also 
respond  to  release  from  the  particular  restrictive 
condition  by  initiating  DNA  synthesis  and  cell 
division  although  the  kinetics  of  the  response 
differs among cell types (reviewed in reference 20). 
One  need  expose  SMC  to  medium  containing 
platelet factors  for only 60 min or less (Fig. 4) to 
stimulate as many cells to initiate DNA synthesis 
as are stimulated by a  24-h exposure.  We cannot 
be  sure  that  simply  removing  the  cells  from 
PPPS+PF  or WBS medium and washing them in 
serum-free  buffer  disengages  the  active  agent(s) 
from the cells. However, these results support the 
notion of a "serum-sensitive" phase followed by a 
"serum-insensitive" phase  (19,  23)  for  the  initia- 
tion  of  DNA  synthesis  in  cultured  cells.  In  this 
system the minimum time as estimated was shorter 
than that  obtained in other  systems (17,  19,  23). 
This result may be at least partially explained by 
the  different  conditions  utilized  to  render  cells 
quiescent  in  our  studies.  Other  investigators de- 
creased the serum concentration (23) or omitted it 
entirely (17,  19). 
The  variation  in  the  maximal  labeling  index 
observed in Figs. 3 and 4 is probably due to the fact 
that  cells  from  different  donor  animals  were 
utilized  in  these  experiments  and  that  there  ap- 
pears to  be a  difference in the growth fraction of 
SMC cultured from different animals (18) (Nist et 
al., manuscript in preparation). 
Mode of A ction of Platelet Factor(s) 
These  observations support  a  hypothesis which 
proposes  that  platelet  factor(s)  functions  as  a 
regulatory  agent  to  stimulate  cell  proliferation 
(16).  The  fact  that  the  proliferative responses of 
widely varying numbers of cells to low (5 ~g/ml) 
concentrations of this material are quantitatively 
similar, and that cells need be in the presence of the 
platelet factor(s) for only a  relatively short period 
of time supports this idea. These and other experi- 
ments with primate dermal fibroblasts (13) demon- 
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similar to  that  seen  for  smooth  muscle (16),  and 
suggest  a  ubiquitous  role  for  platelet  factors  in 
inducing  proliferation  of  at  least  these  types  of 
cells  and  of 3T3  cells  (9).  Presently,  no data  are 
available regarding the site or mechanism of action 
of the platelet factor(s). Experiments involving the 
purification, characterization,  and further tests of 
the  biological  activity  of  platelet  factor(s)  are 
currently in progress. 
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